Eli Lilly, Boehringer roll out video game for doctors to highlight cardio-renal-metabolic disease connections

Like the pipes in the plumbing of a building, the heart, kidneys and endocrine system are interwoven. Disease in one area will often affect the others.

Yet specialists treating patients with cardiovascular, renal and metabolic diseases—known collectively as CRM—too often focus only on their own areas of expertise.

Drugmakers Eli Lilly and Boehringer Ingelheim want to change that, and they've turned to gaming to encourage a more cooperative approach at a time when their Jardiance diabetes drug is moving toward a key approval in patients with chronic kidney disease with or without diabetes.